Noramco
Noramco
Noramco
  • About Us
    • About Noramco
    • Our People
    • Leadership
    • Excellence in Compliance
    • Minimizing Risk
  • Products & Solutions
    • Active Pharmaceutical Ingredients
      • Active Pharmaceutical Ingredients
      • Nal Family of Antagonists
      • ADHD / Stimulants
      • Full Product List
    • Noramco Solutions
      • Noramco Solutions
      • Clinical Supply
      • Controlled Substance Building Blocks and Intermediates
    • Platform Technologies
      • Platform Technologies
      • Platform Technology: Custom Synthesis
    • Reference Standards
      • Reference Standards
      • Reference Standards: Custom Synthesis
    • Reference Standards Store
  • Careers
  • News & Events
    • News & Events
    • Press Releases
  • Contact

Sort by

  • Default sorting
  • Sort by popularity
  • Sort by newness
  • Sort by price: low to high
  • Sort by price: high to low

View

  • 9 items
  • 15 items
  • 30 items

Showing 1–9 of 23 results

  • 69_10-Hydroxyhydrocodone-Base
    Quick ViewSelect options

    10-Hydroxyhydrocodone Base (CII)

    $1,438.00 – $5,752.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 1004312-79-1 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-1020-**
    Quick ViewSelect options
  • ref-standards-vial-temp
    Quick ViewSelect options

    10-Ketohydrocodone Base (CII)

    $1,438.00 – $5,752.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 1273112-37-0 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-2016-**
    Quick ViewSelect options
  • ref-standards-vial-temp
    Quick ViewRead more

    10-β-Hydroxyhydrocodone (CII)

    <span style="color: #000000;"><strong>CAS#</strong></span> 184884-65-9 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-2201-**
    Quick ViewRead more
  • 72_6-b-Tetrahydrothebaine-Base
    Quick ViewSelect options

    6-β-Tetrahydrothebaine Base (CII)

    $863.00 – $3,452.00
    <span style="color: #000000;"><strong>OTHER NAMES:</strong></span> EP Impurity G <span style="color: #000000;"><strong>CAS#</strong></span> 41714-53-8 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-1017-**
    Quick ViewSelect options
  • 73_8,14-dihydrothebaine
    Quick ViewSelect options

    8,14-dihydrothebaine (CII)

    $575.00 – $2,300.00
    <span style="color: #000000;"><strong>OTHER NAMES:</strong></span> EP Impurity J <span style="color: #000000;"><strong>CAS#</strong></span> 561-25-1 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0995-**
    Quick ViewSelect options
  • 61_Codeine-Base
    Quick ViewSelect options

    Codeine Base (CII)

    $232.00 – $1,160.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 76-57-3 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0009-**
    Quick ViewSelect options
  • 62_Codeine-6-methyl-Ether-Base
    Quick ViewSelect options

    Codeine-6-methyl Ether Base (CII)

    $288.00 – $1,152.00
    <span style="color: #000000;"><strong>OTHER NAMES:</strong></span> O-Methylcodeine; EP Impurity A <span style="color: #000000;"><strong>CAS#</strong></span> 2859-16-7 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0903-**
    Quick ViewSelect options
  • 63_Codeinone-Base
    Quick ViewSelect options

    Codeinone Base (CII)

    $1,150.00 – $4,600.00
    <span style="color: #000000;"><strong>CAS#</strong></span> 467-13-0 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0998-**
    Quick ViewSelect options
  • 77_Dihydrocodeine-Base
    Quick ViewSelect options

    Dihydrocodeine Base (CII)

    $288.00 – $1,152.00
    <span style="color: #000000;"><strong>OTHER NAMES:</strong></span> EP Impurity B, USP Impurity <span style="color: #000000;"><strong>CAS#</strong></span> 125-28-0 <span style="color: #000000;"><strong>NDC#</strong></span> 51634-0088-**
    Quick ViewSelect options
  • 1
  • 2
  • 3

Recent Articles

  • Noramco CEO Lee Karras discusses $25 million Halo investment with PharmTech
  • Diversifying the Supply of Raw Materials
  • Noramco Announces Strategic Alignment with Purisys and Halo Pharma, Launching the Noramco Group as an Integrated North American-Based API and Drug Product Supply Chain Services Provider
  • Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
  • Noramco Announces Submission and Reactivation of the Drug Master File for Active Pharmaceutical Ingredient Methylnaltrexone Bromide
Copyright 2025 Noramco. All Rights Reserved. Contact | Legal Notice | Privacy Policy | Terms & Conditions | Benefits Transparency Mandate